Nacionalni portal odprte znanosti

Scholars of “dead tree technologies” feel increasingly uneasy in a culture overwhelmingly consumed with innovation. Although we may “live in a condition of perpetual flux,” David Thorburn hopes that “we won’t allow utopians and futurists to intimidate us.” Moderator Peter Walsh poses a series of que ...

Genzyme is a leader in personalized medicine, as Mark Bamforth demonstrates. For instance, the company collects cartilage from a single patient, grows it in the lab, and sends it back securely to that same patient. The system, says Bamforth, tolerates “no mix ups.” But the company also deals in drug ...